SciClone Pharmaceuticals Stock Price Up 7.1% on Strong Earnings (SCLN)
Shares of SciClone Pharmaceuticals (NASDAQ:SCLN) rose 7.1% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings, American Banking News reports. The company traded as high as $5.64 and last traded at $5.40, with a volume of 527,469 shares. The stock had previously closed at $5.04.
The company reported $0.20 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.10 by $0.10. The company had revenue of $32.50 million for the quarter, compared to the consensus estimate of $33.40 million. During the same quarter in the prior year, the company posted ($0.04) earnings per share. The company’s quarterly revenue was up 10.9% on a year-over-year basis.
The stock has a 50-day moving average of $5.09 and a 200-day moving average of $4.86. The company has a market cap of $278.1 million and a P/E ratio of 25.33.
SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.
Receive News & Ratings for SciClone Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciClone Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.